Procedural details and complications
| TIMI 0 | TIMI 1 | TIMI 2 | TIMI 3 | Total | P Value | |
|---|---|---|---|---|---|---|
| No. of patients | 110 | 20 | 61 | 114 | 305 | |
| Ictus to arterial puncture (hr) (mean) | ||||||
| Median (IQR) | 4.5 ± 2.1 | 4.5 ± 1.6 | 4.3 ± 1.6 | 4.2 ± 1.5 | 4.4 ± 1.8 | NS |
| 4.3 (3.0–5.6) | 4.1 (3.3–5.4) | 4.4 (3.2–5.7) | 4.2 (3.1–5.2) | 4.3 (3.1–5.5) | ||
| Ictus to procedure end (hr) (mean) | ||||||
| Median (IQR) | 6.6 ± 2.1 | 6.93 ± 2.0 | 6.3 ± 1.9 | 5.8 ± 1.6 | 6.3 ± 1.9 | .004 |
| 6.5 (5.5–7.8) | 7.1 (5.7–8.2) | 6.0 (5.0–7.7) | 5.8 (4.7–6.9) | 6.1 (5.0–7.5) | ||
| No. of passes | ||||||
| 1 | 9.1% | 25.0% | 31.1% | 34.2% | 23.9% | <.001 |
| 2 | 18.2% | 15.0% | 16.4% | 23.7% | 19.7% | |
| 3 | 30.0% | 15.0% | 21.3% | 22.8% | 24.6% | |
| 4 | 13.6% | 5.0% | 19.7% | 11.4% | 13.4% | |
| >4 | 29.1% | 40% | 11.5% | 7.9% | 18.4% | |
| Use of adjuvant | 40.9% | 45.0% | 32.8% | 36.0% | 37.7% | NS |
| Procedure-related clinically significant AE | 10.0% | 0.0% | 6.6% | 3.5% | 6.2% | .09 |
| Symptomatic bleeding events | 12.7% | 10.0% | 8.2% | 5.3% | 8.9% | NS |
| PH-2 events | 9.1% | 0.0% | 3.2% | 3.7% | 4.9% | NS |
Note:—IQR indicates interquartile range; NS, not significant; AE, adverse events.